2002
DOI: 10.1093/carcin/23.1.143
|View full text |Cite
|
Sign up to set email alerts
|

Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl

Abstract: Pharmacologically safe compounds that can inhibit the proliferation of tumor cells have potential as anticancer agents. Curcumin, a diferuloylmethane, is a major active component of the food flavor turmeric (Curcuma longa) that has been shown to inhibit the proliferation of a wide variety of tumor cells. The apoptotic intermediates through which curcumin exhibits its cytotoxic effects against tumor cells are not known, and the participation of antiapoptotic proteins Bcl-2 or Bcl-xl in the curcumin-induced apop… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

16
220
2
3

Year Published

2006
2006
2015
2015

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 369 publications
(244 citation statements)
references
References 60 publications
16
220
2
3
Order By: Relevance
“…One of the more extensively studied compounds in this group is curcumin, a diferuloylmethane derived from turmeric, which has been shown to suppress NF-kB activation and NF-kB-dependent gene expression. Previous studies had indicated that curcumin has strong antitumor effects on AML and prostate cancer cell lines (Mukhopadhyay et al, 2001;Anto et al, 2002). Recently, curcumin has been shown to induce growth arrest and apoptosis in mantle cell lymphoma cell lines (Shishodia et al, 2005), where it suppressed the expression of the genes encoding cyclin D1, Bcl-2 and Bcl-xL, all known NF-kB target genes.…”
Section: Non-steroid Anti-inflammatory Drugsmentioning
confidence: 98%
“…One of the more extensively studied compounds in this group is curcumin, a diferuloylmethane derived from turmeric, which has been shown to suppress NF-kB activation and NF-kB-dependent gene expression. Previous studies had indicated that curcumin has strong antitumor effects on AML and prostate cancer cell lines (Mukhopadhyay et al, 2001;Anto et al, 2002). Recently, curcumin has been shown to induce growth arrest and apoptosis in mantle cell lymphoma cell lines (Shishodia et al, 2005), where it suppressed the expression of the genes encoding cyclin D1, Bcl-2 and Bcl-xL, all known NF-kB target genes.…”
Section: Non-steroid Anti-inflammatory Drugsmentioning
confidence: 98%
“…Curcumin is one of the most potent activators of apoptosis in tumor cells [16]. We investigated whether GSH can modulate curcumin's ability to induce apoptosis.…”
Section: Glutathione Inhibits Curcumin-induced Cell Deathmentioning
confidence: 99%
“…This phytochemical has also been shown to suppress the proliferation of a wide variety of tumor cells by downregulating c-myc [6], cyclin D1 [12], activator protein-1 (AP-1) [13], phosphatidylinositol-3-kinase/AKT signaling [14], and epidermal growth factor receptor (EGFR) signaling [15]. Curcumin can also induce apoptosis through the modulation of antiapoptotic gene products [2,6] and BID cleavage, cytochrome c release, and caspase-9 activation, leading to caspase-3 activation [16]. More recently, curcumin was found to bind to thioredoxin reductase and alkylate a critical cysteine residue, thus converting the activity of the enzyme to NADPH oxidase [17].…”
Section: Introductionmentioning
confidence: 99%
“…4A, upper panel) and the proapoptotic protein Bax in a time-dependent manner. Because chemotherapeutic agents induce apoptosis through the caspase-8-mediated cleavage of Bid, a proapoptotic member of the bcl-2 family [34], we investigated guggulsterone's effect on Bid cleavage. Western blot analysis demonstrated that guggulsterone also induced Bid cleavage in a time-dependent manner (Fig.…”
Section: Guggulsterone Activates Caspase-8 and Induces Bid Cleavage mentioning
confidence: 99%